180 related articles for article (PubMed ID: 20406994)
1. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.
Lai J; Lehman ML; Dinger ME; Hendy SC; Mercer TR; Seim I; Lawrence MG; Mattick JS; Clements JA; Nelson CC
RNA; 2010 Jun; 16(6):1156-66. PubMed ID: 20406994
[TBL] [Abstract][Full Text] [Related]
2. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
[TBL] [Abstract][Full Text] [Related]
3. SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Cancer Discov; 2012 Jul; 2(7):582-5. PubMed ID: 22787087
[TBL] [Abstract][Full Text] [Related]
4. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract][Full Text] [Related]
5. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
[TBL] [Abstract][Full Text] [Related]
6. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
Qin F; Zhang Y; Liu J; Li H
Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
[TBL] [Abstract][Full Text] [Related]
7. KLK4T2 Is a Hormonally Regulated Transcript from the
Lundwall Å; Ylitalo EB; Wikström P; Brattsand M
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884832
[TBL] [Abstract][Full Text] [Related]
8. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
[TBL] [Abstract][Full Text] [Related]
9. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
[TBL] [Abstract][Full Text] [Related]
10. Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer.
Chakravarthi BV; Dedigama-Arachchige P; Carskadon S; Sundaram SK; Li J; Wu KH; Chandrashekar DS; Peabody JO; Stricker H; Hwang C; Chitale DA; Williamson SR; Gupta NS; Navone NM; Rogers C; Menon M; Varambally S; Palanisamy N
Neoplasia; 2019 Oct; 21(10):989-1002. PubMed ID: 31446281
[TBL] [Abstract][Full Text] [Related]
11. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
Avgeris M; Stravodimos K; Scorilas A
Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of the KLK4 locus with risk of prostate cancer.
Lose F; Srinivasan S; O'Mara T; Marquart L; Chambers S; Gardiner RA; Aitken JF; ; Spurdle AB; Batra J; Clements JA
PLoS One; 2012; 7(9):e44520. PubMed ID: 22970239
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.
Xi Z; Klokk TI; Korkmaz K; Kurys P; Elbi C; Risberg B; Danielsen H; Loda M; Saatcioglu F
Cancer Res; 2004 Apr; 64(7):2365-70. PubMed ID: 15059887
[TBL] [Abstract][Full Text] [Related]
15. Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.
Väänänen RM; Lilja H; Cronin A; Kauko L; Rissanen M; Kauko O; Kekki H; Vidbäck S; Nurmi M; Alanen K; Pettersson K
Clin Biochem; 2013 May; 46(7-8):670-4. PubMed ID: 23391636
[TBL] [Abstract][Full Text] [Related]
16. Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer.
Lai J; An J; Nelson CC; Lehman ML; Batra J; Clements JA
Biol Chem; 2014 Sep; 395(9):1127-32. PubMed ID: 25153393
[TBL] [Abstract][Full Text] [Related]
17. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.
Korkmaz KS; Korkmaz CG; Pretlow TG; Saatcioglu F
DNA Cell Biol; 2001 Jul; 20(7):435-45. PubMed ID: 11506707
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
[TBL] [Abstract][Full Text] [Related]
19. Large-scale analysis of antisense transcription in wheat using the Affymetrix GeneChip Wheat Genome Array.
Coram TE; Settles ML; Chen X
BMC Genomics; 2009 May; 10():253. PubMed ID: 19480707
[TBL] [Abstract][Full Text] [Related]
20. Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera.
Day CH; Fanger GR; Retter MW; Hylander BL; Penetrante RB; Houghton RL; Zhang X; McNeill PD; Filho AM; Nolasco M; Badaro R; Cheever MA; Reed SG; Dillon DC; Watanabe Y
Oncogene; 2002 Oct; 21(46):7114-20. PubMed ID: 12370833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
